Featured Research

from universities, journals, and other organizations

Tobacco plant-made therapeutic thwarts West Nile virus

February 3, 2010
Arizona State University
A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study.

Qiang "Shawn" Chen and lead author Huafang "Lily" Lai arrested West Nile virus infection with a new therapeutic manufactured from tobacco plants.
Credit: Barb Backes, Biodesign Institute at ASU

A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study by Arizona State University scientist Qiang Chen and his colleagues.

Related Articles

Chen, a researcher at Arizona State University's Biodesign Institute and professor in the PolyTechnic Campus' College of Technology and Innovation, is the first to demonstrate a plant-derived treatment to successfully combat West Nile virus after exposure and infection. The research appears in the Proceedings of the National Academy of Sciences (advanced online edition).

There are currently no available vaccines against West Nile, nor effective therapeutics for human use, so the current findings are a considerable advancement and may offer the best hope thus far that the West Nile virus infection can be stopped, even several days after viral infection.

West Nile virus has made alarming inroads in North America, causing disease outbreaks throughout the U.S., as well as in areas of Canada, Mexico, the Caribbean and South America. Elderly individuals and those with depressed immunity are particularly vulnerable to West Nile, a mosquito-borne illness which can cause a potentially lethal inflammation of the brain.

Chen's group demonstrated the versatility of plant-based biotechnology. "The goal of this research was twofold," said Chen. "First, we wanted to show proof-of- concept, demonstrating that plant-made antibodies can work as effective post-exposure therapeutics. Secondly, we've sought to develop a therapeutic which can be made inexpensively so that the health care systems in developing countries can afford it."

Issues of affordability for such antibody-based treatments are central to the challenge, Chen stresses, with the costs for development of a traditional pharmaceutical mammalian cell line production facility often running into the tens of millions of dollars. Besides being inexpensive, plants offer other advantages. Mammalian cell lines may run the risk of harboring animal pathogens such as viruses or infectious protein agents known as prions, not found in plants. Plants also allow production of pharmaceutical products to be easily scaled up to whatever quantities are required. "With mammalian cells systems, the physical size of the bioreactor is limiting," said Chen, "whereas with plants, we can just plant another acre."

The study examined antibodies against West Nile virus derived from mammalian cell lines and compared their effectiveness with those extracted from plants. The plants used to produce the antibodies are a relative of common tobacco, a member of the Solanceae family of plants, which produce abundant leaves for harvesting material and are also prolific seed producers. Seven days after the introduction of antibody genes into plants, the leaves are harvested, homogenized and purified to remove extraneous material.

The strategy for gene insertion is to use the specific machinery of the tobacco mosaic virus and potato virus X (PVX) to carry the genes of interest into the plants, where they can be expressed, yielding a human monoclonal antibody known as hu-E16. The gene expression occurs in just a week's time, making the production process highly efficient.

The monoclonal antibody, once injected into the recipient, binds to a particular surface protein of the virus. That binding site is also the one used by the virus to attach itself to mammalian host cells, and once it is occupied, the virus' cell-binding (and infectious) capacity is neutralized.

Cell-derived versions of this antibody have already demonstrated impressive effectiveness, protecting mice from WNV-induced mortality even several days after infection. Chen's research shows comparable effectiveness using tobacco-plant derived monoclonal antibodies. Indeed, the results in the groups of mice tested, were essentially indistinguishable. The therapeutic, Chen emphasizes, is effective in very small dosages, (50-200 micrograms), and only one dose is required to clear the virus from an infected individual's system.

The effectiveness of the plant expression system is dependent in part on the optimization of the antibody DNA sequence, which helps to ensure a high level of expression in the plants. "The goal is to make more of the protein and for it to persist longer before it is degraded, " said Chen. "Optimization helps." The strategy permitted the group to set a record for the antibody yield produced by the transgenic tobacco plants -- an increase from 500 micrograms of antibody per gram of leaf tissue to 800 micrograms per leaf.

Because the monoclonal antibody therapeutic binds to a conserved region of the viral surface, it can be effective against a variety of West Nile virus stains and potentially against other flaviviral strains. Here, another advantage of plant-derived as opposed to animal-derived antibodies becomes important. If an individual is exposed to a variant strain of virus differing in some particulars from the antibody used to treat it, there is a chance in the case of the mammalian cell-derived therapy to actually worsen the condition, through an effect known as antibody dependent enhancement. The process has been studied in some detail in dengue fever, a related flavivirus. Chen emphasizes that plant-based antibodies lack the capacity to bind with a critical receptor implicated in the antibody dependent enhancement effect, making them potentially safer for use.

The completion of this research relied on the efforts of a large, interdisciplinary team, including lead author Huafang "Lily" Lai. Michael Diamond of Washington University collaborated in studies with the mouse model. In addition to Chen's ASU scientist colleagues, Thomas Keller, an undergraduate in ASU's School of Life Sciences Undergraduate Research program appears as a co-author of the PNAS paper, having carried out much of the critical protein expression and characterization work. "This was a very remarkable achievement for an undergraduate student," Chen points out. The research was supported by grants from the National Institute of Allergy and Infectious Diseases, and Keller's work was supported in part through the Howard Hughes Fellowship for Undergraduate Research.

While the group's focus has been on West Nile Virus, Chen believes the plant-based antibody approach could provide highly effective, cost efficient therapeutics for other diseases, including related flavivirus infections such as dengue fever and Japanese encephalitis, if the successes in mice can be replicated in humans.

One challenge in treating a virus like West Nile, which targets the central nervous system, is that current antibody therapeutics are unable to pursue the virus into its sanctuaries in the human brain, due to the existence of the blood brain barrier. If this obstacle can be overcome, it may be possible to produce therapeutics capable of eradicating the infection even after 6 or 7 days, when a significant amount of virus has colonized brain tissue.

Toward this end, Chen is now working on bifunctional antibodies, capable of binding with virus particles as well as attaching to receptors in the brain, allowing the antibody to migrate past the blood brain threshold. If successful, the technique may allow treatment of other, currently intractable infectious and neurological diseases. "If we can find a way to deliver therapeutics of this sort into the brain it will be really significant," said Chen.

Story Source:

The above story is based on materials provided by Arizona State University. The original article was written by Richard Harth, Biodesign Institute science writer. Note: Materials may be edited for content and length.

Cite This Page:

Arizona State University. "Tobacco plant-made therapeutic thwarts West Nile virus." ScienceDaily. ScienceDaily, 3 February 2010. <www.sciencedaily.com/releases/2010/02/100201171643.htm>.
Arizona State University. (2010, February 3). Tobacco plant-made therapeutic thwarts West Nile virus. ScienceDaily. Retrieved April 21, 2015 from www.sciencedaily.com/releases/2010/02/100201171643.htm
Arizona State University. "Tobacco plant-made therapeutic thwarts West Nile virus." ScienceDaily. www.sciencedaily.com/releases/2010/02/100201171643.htm (accessed April 21, 2015).

Share This

More From ScienceDaily

More Plants & Animals News

Tuesday, April 21, 2015

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

Going Ape: Sierra Leone Chimpanzees Hail Ebola Retreat

Going Ape: Sierra Leone Chimpanzees Hail Ebola Retreat

AFP (Apr. 21, 2015) As money runs out at Tacugama Chimpanzee Sanctuary in Sierra Leone, around 85 chimps are facing homelessness. The centre closed when the Ebola epidemic was ravaging the country but now that closure is beginning to look permanent. Video provided by AFP
Powered by NewsLook.com
Blue Bell Recalls All Products

Blue Bell Recalls All Products

AP (Apr. 21, 2015) Blue Bell Creameries voluntary recalled for all of its products after two samples of chocolate chip cookie dough ice cream tested positive for listeria, a potentially deadly bacteria. Blue Bell&apos;s President and CEO issued a video statement. (April 21) Video provided by AP
Powered by NewsLook.com
Research Says Complex Tools Might Not Be 'Our Thing' Anymore

Research Says Complex Tools Might Not Be 'Our Thing' Anymore

Newsy (Apr. 21, 2015) The use of complex tools has often been seen as a defining characteristic of humanity, but that notion is now in question. Video provided by Newsy
Powered by NewsLook.com
Deepwater And Dolphins: The Oil Spill's Impact 5 Years On

Deepwater And Dolphins: The Oil Spill's Impact 5 Years On

Newsy (Apr. 20, 2015) Five years on, the possible environmental impact of the Deepwater Horizon spill includes a sustained die-off of bottlenose dolphins, among others. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories

Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins